title: Nodoventricular accessory pathways in PRKAG2-dependent familial preexcitation syndrome reveal a disorder in cardiac development.
abstract: BACKGROUND
  Familial preexcitation syndrome is linked to mutations in PRKAG2. Previous studies on the R302Q mutation have provided evidence for a remarkably high proportion of otherwise rare accessory pathways with atrioventricular (AV) node-like conduction properties (Mahaim fibers). Yet, histopathologic proof is still lacking. We aimed to provide such proof.
  
  
  RESULTS
  We retrospectively studied the medical records of 17 members of a 5-generation family. Five subjects died prematurely. The R302Q mutation was found in 8 living subjects and 2 deceased subjects (obligate carriers). Cardiac hypertrophy was found in 7 mutation carriers. ECGs compatible with preexcitation were found in 13 subjects and AV block at varying degrees in 5 subjects. All mutation carriers had electrocardiographic evidence of preexcitation, AV block, or both. Three individuals had high-grade AV block with preexcited conducted beats. Electrophysiological studies in 3 individuals revealed bypasses with AV node-like properties. Histopathologic studies of 1 suddenly deceased mutation carrier revealed concentric hypertrophy of the left ventricle with extensive myocardial disarray associated with slight interstitial fibrosis but no lysosomal-bound glycogen. Moreover, there were 3 small nodoventricular tracts (Mahaim fibers) passing through the central fibrous body and connecting the AV node with the working myocardium of the interventricular septum.
  
  
  CONCLUSIONS
  Preexcitation associated with the R302Q mutation in PRKAG2 is associated with Mahaim fibers. These findings support the novel insight that PRKAG2 may be involved in the development of the cardiac conduction system.
authors.affiliation: Heart Failure Research Center, Department of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. h.l.tan@amc.nl
authors.forename: Hanno L
authors.initials: HL
authors.lastname: Tan
authors.forename: Allard C
authors.initials: AC
authors.lastname: van der Wal
authors.forename: Maria E
authors.initials: ME
authors.lastname: Campian
authors.forename: Hittjo H
authors.initials: HH
authors.lastname: Kruyswijk
authors.forename: Bram
authors.initials: B
authors.lastname: ten Hove Jansen
authors.forename: Dirk-Jan
authors.initials: DJ
authors.lastname: van Doorn
authors.forename: Henk J
authors.initials: HJ
authors.lastname: Oskam
authors.forename: Anton E
authors.initials: AE
authors.lastname: Becker
authors.forename: Arthur A M
authors.initials: AA
authors.lastname: Wilde
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000235:genetics* / Q000378:metabolism; D000328:Adult; D004247:DNA / Q000235:genetics*; D004252:DNA Mutational Analysis; D018450:Disease Progression; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D008297:Male; D009154:Mutation; D009206:Myocardium / Q000473:pathology*; D010375:Pedigree; D011227:Pre-Excitation, Mahaim-Type / Q000201:enzymology / Q000235:genetics* / Q000503:physiopathology; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D004247:DNA; C526223:PRKAG2 protein, human; D055372:AMP-Activated Protein Kinases